Your browser doesn't support javascript.
loading
Local Application of Mineral-Coated Microparticles Loaded With VEGF and BMP-2 Induces the Healing of Murine Atrophic Non-Unions.
Orth, M; Fritz, T; Stutz, J; Scheuer, C; Ganse, B; Bullinger, Y; Lee, J S; Murphy, W L; Laschke, M W; Menger, M D; Pohlemann, T.
Afiliación
  • Orth M; Department of Trauma, Hand and Reconstructive Surgery, Saarland University, Homburg, Germany.
  • Fritz T; Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
  • Stutz J; Department of Trauma, Hand and Reconstructive Surgery, Saarland University, Homburg, Germany.
  • Scheuer C; Department of Trauma, Hand and Reconstructive Surgery, Saarland University, Homburg, Germany.
  • Ganse B; Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
  • Bullinger Y; Institute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
  • Lee JS; Department of Trauma, Hand and Reconstructive Surgery, Saarland University, Homburg, Germany.
  • Murphy WL; Werner Siemens Endowed Chair of Innovative Implant Development (Fracture Healing), Saarland University, Homburg, Germany.
  • Laschke MW; Department of Trauma, Hand and Reconstructive Surgery, Saarland University, Homburg, Germany.
  • Menger MD; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States.
  • Pohlemann T; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States.
Front Bioeng Biotechnol ; 9: 809397, 2021.
Article en En | MEDLINE | ID: mdl-35087807
ABSTRACT
Deficient angiogenesis and disturbed osteogenesis are key factors for the development of nonunions. Mineral-coated microparticles (MCM) represent a sophisticated carrier system for the delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP)-2. In this study, we investigated whether a combination of VEGF- and BMP-2-loaded MCM (MCM + VB) with a ratio of 12 improves bone repair in non-unions. For this purpose, we applied MCM + VB or unloaded MCM in a murine non-union model and studied the process of bone healing by means of radiological, biomechanical, histomorphometric, immunohistochemical and Western blot techniques after 14 and 70 days. MCM-free non-unions served as controls. Bone defects treated with MCM + VB exhibited osseous bridging, an improved biomechanical stiffness, an increased bone volume within the callus including ongoing mineralization, increased vascularization, and a histologically larger total periosteal callus area consisting predominantly of osseous tissue when compared to defects of the other groups. Western blot analyses on day 14 revealed a higher expression of osteoprotegerin (OPG) and vice versa reduced expression of receptor activator of NF-κB ligand (RANKL) in bone defects treated with MCM + VB. On day 70, these defects exhibited an increased expression of erythropoietin (EPO), EPO-receptor and BMP-4. These findings indicate that the use of MCM for spatiotemporal controlled delivery of VEGF and BMP-2 shows great potential to improve bone healing in atrophic non-unions by promoting angiogenesis and osteogenesis as well as reducing early osteoclast activity.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Bioeng Biotechnol Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Bioeng Biotechnol Año: 2021 Tipo del documento: Article País de afiliación: Alemania